Rtw Investments, LP Biomea Fusion, Inc. Transaction History

Rtw Investments, LP

  • $6.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.39 - $9.03 $2.61 Million - $5.36 Million
-593,846 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$7.22 - $12.72 $1.71 Million - $3.01 Million
-236,948 Reduced 28.52%
593,846 $4.42 Million
Q2 2021

Aug 13, 2021
BUY
$13.65 - $20.93 $11.3 Million - $17.4 Million
830,794 New
830,794 $12.3 Million

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $114M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email